Cotinga Pharmaceuticals Inc

(COT:CHI)

By |

Profile

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical research, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene and the second clinical research, COTI-219, is a novel oral small molecule compound targeting the mutant forms. The company uses various technologies that are Chemas: which is a multi-staged computational platform technology based upon a hybrid of machine learning technologies and proprietary algorithms, Rosalind; which is a smart data platform designed to provide better personalized treatment options to cancer patients, and Chemfirm; which is positioned to rapidly and meaningfully improve the drug discovery process and improve biopharmaceutical investment performance.

Contact Information

Website: cotingapharma.com
Email: gkelly@criticaloutcome.com
Main Phone: +1 519 858-5157
Address: 100 Collip Circle
Address 2: Suite 230B, The Mogenson Centre
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: CDX
CEO: Alison Silva
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 21.6 21.6 21.6 21.6
Low Target Price Estimate 4.5 4.5 4.5 4.5
Mean Target Price Estimate 13.05 13.05 13.05 13.05
Standard Deviation 12.09 12.09 12.09 12.09
Date of Most Recent Estimate 02/01/18 02/01/18 02/01/18 02/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3